Delivery Order SPE2DR25D2010-SPE2DR26F4ZWH
- Not listed
- The Defense Logistics Agency awarded a $12,047.87 delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price contract with no set-aside designation, meaning the award was made through full and open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $8,957.53. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 30, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,936.87 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Durolane 60 mg/3 ml syringes. This non-set-aside, competitively awarded contract reflects a firm fixed-price transaction with an ultimate completion date of January 9, 2026, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order operates as a child contract under Cencora, Inc., the parent pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order valued at $11,775.40 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on January 28, 2026, with an ultimate completion date of January 29, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $5,495.41 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on December 11, 2025, with completion targeted for December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's significantly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Durolane 60 mg/3 ml syringes with a contract value of $2,290.11 and an ultimate completion date of November 25, 2025. This non-competitive delivery order utilizes firm fixed pricing and is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement designated SPE2DX and running through...
- The Defense Logistics Agency awarded a delivery order valued at $22,791.84 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on January 13, 2026, with an ultimate completion date of January 14, 2026. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,931.14 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a $4,730.32 delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for the supply of Durolane 60 mg/3 mL syringes. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of May 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZWHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,612.80 to Amerisourcebergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes (3 mL quantity) on January 27, 2026, with an ultimate completion date of January 28, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. This delivery order is issued under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which has a potential value of $999,999,999.00 through December 2026 and serves as the comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement. The parent company, Cencora, Inc., holds the primary IDC with the Defense Logistics Agency and demonstrates extensive capability in supplying diverse pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities and federal healthcare systems globally. This particular delivery order for Durolane, a hyaluronic acid injection used for osteoarthritis treatment, reflects the company's continued role in fulfilling medical supply needs for the Department of Defense and its healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/26/26 |